Background Solid organ transplant recipients (SOTR) with a pretransplant malignancy
(PTM) are at increased risk for cancer recurrence. However, it is unclear whether differences …

Background Solid-organ transplant recipients with pretransplant malignancies (PTM) have
worse overall survival (OS) compared to recipients without history of malignancy. However, it …

Solid organ transplant recipients (SOTR) with a pre-transplant malignancy (PTM) have been
thought to be at high risk of cancer recurrence. However, recent population-based studies …

Background De novo posttransplant malignancy (PTM) is a serious complication of
transplantation. Incidences may vary among solid organ transplantations (SOTs) and may …

Background It is unclear to what extent cancer history affects posttransplantation mortality in
solid organ transplant recipients. Methods We identified a Swedish population-based cohort …

Importance Solid-organ transplant recipients (SOTRs) are at greater risk of developing some
cancers than the general population; however, because they are also at increased risk of …

Solid organ transplant recipients (OTRs) have an increased cancer risk but their survival
once diagnosed with cancer has seldom been assessed. We therefore investigated cancer …

Solid organ transplant (SOT) recipients are at risk of developing posttransplant malignancy
that, along with cardiovascular disease and infection, remains a leading cause of …

Background. Transplant recipients are at increased risk of malignancy; however, the
influence of transplantation on cancer outcomes has not been rigorously defined. The …

Cancer is a significant cause of morbidity and mortality after solid organ transplantation
(SOT) and related to lifelong immunosuppression. This retrospective registry study assessed …